Linda Rieswijk, MSc, was born on January 7th 1986 in Amsterdam, the Netherlands. In 2004 she started her bachelor study “Nutrition and Health” at the Wageningen University, specialized in Molecular Nutrition. After her graduation in 2007, she continued her studies with a master in the same field and obtained her degree in September 2009. During her master she did a thesis for 6 months on “Antioxidative characteristics of selenium in peripheral blood mononuclear cells (PBMCs)” within the framework of the Selenium and Prostate cancer (SePros) study. After she finished her master thesis, she went to the UK for 4.5 months to do her internship at the Human Nutrition Research Centre of the Newcastle University. Her internship covered the study of “The tissue specific effect of maternal folate depletion on the epigenetic gene regulation in mice offspring”. On the 1st of January 2010 she started working as a PhD in the area of toxicogenomics at the Department of Health Risk Analysis and Toxicology
(Maastricht University) within a major EU financed research program of the Netherlands Toxicogenomic Centre entitled: “An applied system biology approach to predict chemical safety”. The aim of this PhD project was to elucidate the participation of miRNA and epigenetic changes on transcriptomic responses induced by genotoxic and non-genotoxic compounds in human in vitro liver models. On the 1st of February 2015 she started working as a post-doctoral fellow on the eNanoMapper project (http://www.enanomapper.net). Within this project she will mainly be focusing on the development of comprehensive ontologies for the nanosafety domain.